Insurance by BogdanovaThe Encyclopedia of Insurance and Risk Science

RESEARCH DOSSIER

Variable and Unit-Linked Life Insurance Contract Design

Abstract. Variable and unit-linked life insurance contracts allocate the financial consequences of investment performance and insured death through a single legally governed policy. Their investment units, internal accounts, charges, guarantees, and termination conditions interact dynamically: the same decline in market value can reduce the policyholder's accessible value, increase the insurer's net amount at risk, and accelerate termination if charges can no longer be funded. This monograph develops a documentary and actuarial analysis of that interaction using selected U.S. variable-life regulatory materials, European insurance-based investment product requirements, international financial-reporting guidance, original issuer prospectuses, empirical lapse studies, and foundational financial-economics literature. It separates the policy's contractual benefit formula, the economic location of risk, the legal structure of segregated or linked assets, the actuarial cost of contingent protection, and the accounting consequences of direct participation. Transparent numerical illustrations demonstrate unit-account evolution, the contingent guaranteed death-benefit shortfall, cumulative charges, and surrender behavior. The comparative investigation finds that contractual labels alone cannot resolve economic exposure or accounting classification; the operative benefit schedule, guarantees, termination rights, investment options, and actual supervisory framework must be read together. The evidence further shows why a product's expected investment return cannot measure consumer value without the insurance benefit, fee structure, risk capacity, and likelihood of maintaining coverage. The resulting analytical synthesis identifies the documentary evidence and quantitative tests needed to evaluate individual contracts, while distinguishing observed empirical results from hypothetical scenarios and preserving the limits of the jurisdictions and sources examined.

Keywords: variable life insurance; variable universal life; unit-linked life insurance; insurance-based investment products; separate accounts; investment units; mortality risk; minimum death benefit; policy lapse; surrender value; financial guarantees; policyholder protection; PRIIPs; IFRS 17; Solvency II; product governance.

Introduction

A variable or unit-linked life contract places an investment-sensitive account and a life-contingent promise inside the same contractual relation. Its financial outcome depends on far more than the return of the selected funds. Benefits can depend on whether the insured survives to a valuation date, the age- and risk-related deductions assessed during the intervening period, the benefit option chosen, the presence of loans, and the policyholder's ability to maintain an account balance sufficient for continuing charges. When death occurs during an adverse market, the insurer may owe a larger amount of pure insurance protection than it would owe in a prosperous market. The person purchasing the policy therefore needs a coherent account of two simultaneous exposures, and the researcher requires a method capable of separating them before studying their interaction.

The U.S. Securities and Exchange Commission's variable-life investor explanation identifies an investment-dependent cash value, fees, optional guarantees, and the possibility of lapse. Its account of the contract is an official consumer-oriented description, rather than a definition that governs every country. The European Union's PRIIPs Regulation identifies insurance-based investment products partly through exposure of maturity or surrender value to market fluctuations. These descriptions overlap in economic subject matter, but their legal and institutional boundaries differ. An insurer may also offer unit-linked coverage whose death benefit is simply linked to the unit fund, or a hybrid policy combining guaranteed and market-exposed elements. No single commercial title determines the promise.

This study addresses three questions. First, what constitutes a variable or unit-linked life-insurance contract, and what documentary features establish its distinct contractual identity? Second, how do investment allocation, insurance deductions, death benefits, and guarantees determine the location and magnitude of risk as the contract progresses? Third, how do supervisory classifications, observable policyholder behavior, and the limits of available evidence alter conclusions about performance and protection? The method combines contract reconstruction, comparative regulation, elementary contingent-claim mathematics, and critical assessment of selected empirical findings. Original calculations are intentionally illustrative: they are reproduced from explicit assumptions and are not represented as insurer prices or market estimates.

The population of interest is individual investment-linked life contracts with an identifiable insurance benefit and market-sensitive account or linked value. Pure investment-fund ownership, variable annuities without the relevant death-insurance structure, and conventional life-insurance savings contracts enter only as comparators. Product variants matter more than nominal uniformity: a scheduled-premium variable life policy, a flexible-premium variable universal life policy, and a European unit-linked policy may implement different premium obligations, lapse triggers, investment control, and insurance guarantees. Market figures and legal rules are always tied to their actual source populations and jurisdictions.

Definitions, Historical Development, and Documentary Foundations

The contractual object

A working definition follows from the operative contract rather than its sales category. Variable and unit-linked life insurance is a life-contingent arrangement in which at least one value or benefit is determined by reference to investment units, designated fund values, or a separate investment account, while the insurer assumes obligations specified by the policy upon insured death or other covered contingencies. The relevant legal relation is between policyholder and insurer, with designated beneficiaries and sometimes separate owner, insured, and premium payer. The right to choose a subaccount ordinarily confers a contractual allocation instruction; it does not, by itself, mean that the policyholder directly owns underlying securities. That ownership distinction matters for insolvency, taxation, transfer, fund replacement, and claims administration.

In the United States, the SEC's Form N-6 adoption rule describes variable life contracts as providing death benefits and cash values that can vary with the investment experience of a separate account. It also establishes a prospectus framework for separate accounts registered as unit investment trusts offering those contracts. The legal design is dual: the licensed insurer issues insurance obligations while federal securities disclosure addresses the investment-related policy offering. State insurance law and federal securities law operate together in their respective scopes. This is a feature of the U.S. system, not a general characterization of every unit-linked contract globally.

In European legislation, the definition of insurance-based investment product in the PRIIPs Regulation is anchored in maturity or surrender values exposed wholly or partly to market fluctuations. Life contracts paying benefits solely on death or certain incapacity events fall outside the specified PRIIPs scope. The question is consequently not whether the brochure says 'life insurance', but whether contractual financial exposures and regulatory exclusions actually fit the operative legislation. The insurance nature of a contract, the applicable retail-investment information duties, and its accounting treatment are analytically different classifications.

Product families and documentary schedules

A scheduled-premium variable life policy commonly specifies a regular contribution and an investment-sensitive cash value; the way its death benefit adjusts depends on contractual formulas. A flexible-premium variable universal life policy typically allows contributions to vary while monthly insurance and administration deductions continue. The SEC investor description of premium flexibility makes clear that flexibility does not eliminate the requirement to fund charges. Unit-linked products in other markets may use periodic premiums or single premiums, allow switches among internal or externally managed funds, and specify minimum protection as a fixed sum, a percentage of contributions, or another contractual amount. A death-only or nearly pure investment-linked policy should be distinguished from a contract with a substantive additional guaranteed amount under adverse markets.

One historical issuer document supplies useful evidence of the internal product grammar. A publicly filed variable-life policy prospectus describes cash value, death benefits, surrender rights, loans, and dependence on selected investment funds. It demonstrates the documentary combination of insurance clauses with fund-allocation mechanics. It cannot establish the market frequency of those terms, the performance of later policies, or contemporary legal compliance. A second archival variable-life prospectus describes policy loans, loan interest, cash surrender value, and the impact of indebtedness on death proceeds. Its relevance is the contractual interaction of an investment account and financing provisions, not any implied recommendation of its named issuer.

A contract reconstruction should index the schedule of benefits, definition of cash value, definitions of net premium and account value, the unit-pricing date, the amount and timing of each charge, rules for fund switching, death-benefit options, loan and surrender provisions, the definition of grace period, and any no-lapse undertaking. It must then identify which statements are binding policy terms, which are regulatory disclosures, which describe a discretionary practice, and which are merely hypothetical illustrations. Missing this hierarchy can create false claims: an illustrated return is not a guaranteed return, and a prospectus description of an optional rider does not mean the rider is attached to a given policy.

The intellectual lineage of investment-linked guarantees

The financial-economics literature recognized early that investment-linked insurance with a floor includes a contingent financial promise. Brennan and Schwartz (1976), in pricing equity-linked life guarantees, studied a benefit related to a reference asset subject to a guaranteed minimum, interpreting the relevant payoff through option pricing. Their contribution establishes the economic importance of the guarantee's shape; its assumptions do not establish the price of a modern variable universal life policy containing ongoing mortality charges, withdrawals, credit risk, policyholder choice, and state-dependent termination. The historical insight is durable because a downside floor converts an otherwise pass-through investment exposure into an insurer-written contingent obligation.

Møller (1998) developed risk-minimizing hedging for unit-linked insurance, explicitly joining investment-market uncertainty to uncertainty about insured lives. Under the paper's incomplete-market setting, trading ordinary securities alone cannot perfectly eliminate the mortality component. This observation matters in assessing the tempting claim that a matched portfolio automatically immunizes the entire insurance product. An insurer can match fund-sensitive obligations closely while retaining death, longevity, persistency, expense, operational, and counterparty exposures. Risk-transfer methods can redistribute these exposures, but the residual depends on the precise contractual rights and available hedging instruments.

Evidence hierarchy and research boundaries

The primary documentary hierarchy in this dossier is enacted legislative text and operative supervisory or regulator documents, followed by filed issuer terms, current official educational materials, and peer-reviewed economic analyses. An issuer prospectus is primary evidence of a disclosed contractual product, although the policy document and endorsements ultimately determine the rights of its particular parties. A regulator's model law illustrates a policy template and requires enacted state implementation before it creates a binding obligation. The NAIC model-law catalogue lists the Model Variable Contract Law, Model No. 260, and Variable Life Insurance Model Regulation, Model No. 270; it does not itself prove their uniform enactment or effective dates in individual states.

Historical documents, current product disclosures, and national rules are deliberately kept in their dated contexts. The U.S. evidence illustrates separate accounts and flexible-premium variable insurance; the European material addresses retail insurance-based investments and unit-linked supervisory concerns; IFRS material supplies a reporting lens for entities applying that framework. The empirical studies used below concern heterogeneous life insurance portfolios and do not permit universal inference for all contemporary unit-linked products. Those distinctions shape what is warranted in each analytical chapter.

Investment Account Allocation and Contract Cash Flows

Units, subaccounts, and the economic location of exposure

Investment-linked designs translate some or all investable premiums into account units or a contract value referenced to a portfolio. A unit price represents a valuation convention, not a separate promise that the unit's price will remain stable. When a contract specifies the investment options, the policyholder selects an allocation subject to eligibility and timing rules; the insurer or separate-account structure maintains the legal and accounting organization of the assets. The exposure can encompass equities, fixed income, multi-asset investments, currency, and funds with their own fees and liquidity terms. An allocation election determines the policyholder's relative market exposure but normally leaves underwriting, death-benefit administration, contractual fee assessment, and the insured event within the insurer's responsibility.

Under a stylized unit accounting representation, if net premium allocated at time t is P_t(1-l_t), unit price is U_t and the policy has n_t units before a transfer, new units purchased are P_t(1-l_t)/U_t. For multiple funds indexed by j, account value is A_t = sum_j n_(j,t) U_(j,t) plus any specified fixed account. Rebalancing changes the quantities n_j while leaving the value invariant at the trade-time prices before any switching costs, bid-offer spreads, or taxes. A full contract model must specify the settlement date because intra-day fund pricing, transaction cutoffs, suspended dealing, and death-claim valuation are consequential. Unit prices may already reflect fund-level expenses, so subtracting those expenses again from a disclosed net unit price would double-count them.

The initial economic allocation is also affected by premium taxes where applicable, acquisition or sales loads, and cash-value charges. The SEC's list of variable-life fee categories includes sales deductions, mortality and expense charges, insurance costs, and fund expenses. Actual policy charges can be fixed, percentage-based, age-banded, risk-class-dependent, subject to contractual maxima, or contingent on transactions. An academically valid cost comparison must state which fee bases overlap and which charges are deducted before or after fund performance. The same quoted annual percentage does not imply the same economic burden when it applies to premiums, account values, or net amount at risk.

A reproducible account-value identity

To expose the cash-flow sequence, define a simplified annual model with investment account A_t at the beginning of a year, premium P_t, premium load l_t, withdrawals W_t, gross portfolio return r_t, account-value proportional charge m_t, and fixed plus risk charges C_t. Suppose the convention is that net premium and withdrawals are applied first, gross investment return second, the proportional charge third, and C_t last. Then

A_(t+1) = max{0, (A_t + P_t(1-l_t) - W_t)(1+r_t) - C_t}.

The maximum expresses a modeled exhaustion boundary rather than an unconditional promise that the policy remains effective at zero. Real contracts can impose charges monthly, deduct mortality charges before fund appreciation, apply different timing for premium payments, credit fixed-account returns separately, or create indebtedness. A complete legally effective recursion therefore needs contract-specific timing and persistence rules. The identity still exposes the central accounting fact that market returns compound on the account net of substantial recurring charges and benefit-related deductions.

Consider a transparent one-year scenario starting with A_0 = $100,000, no new premium or withdrawal, m = 1.5% after investment return, and a combined fixed and cost-of-insurance deduction of $600 at year-end. With an illustrative +8% gross return, A_1 = $100,000 × 1.08 × 0.985 − $600 = $105,780. With a −25% gross return under identical fees, A_1 = $100,000 × 0.75 × 0.985 − $600 = $73,275. These numbers are calculated illustrations, not observations, quotations from a filed product, or projected performance. The percent charge in the falling market is assessed against a smaller value, but the fixed charge continues. Thus the effective annual burden relative to beginning value becomes less uniform as investment returns diverge. A more stressed market may also require additional premium funding to retain the death cover.

Fee accumulation over long holding periods

Charges affect the terminal account through compounding. To isolate a single mechanism, assume a beginning balance of $100,000, no mortality cost, no withdrawals or premiums, a constant hypothetical gross return of 6% and an annual charge of f assessed after the gross return. After 20 years A_20 = 100,000[(1.06)(1-f)]^20. The comparison between f = 1% and f = 2% describes a difference in the cost of the investment wrapper alone; it is not an overall measure of the value of death protection. Actual return paths are uncertain, fund management expenses may already be included in quoted returns, and policy taxes, rider charges, and mortality deductions would change the outcome. The underlying lesson is that a small difference in annual percentage charges can produce a substantial difference in accessible account value over a long contractual horizon.

The correct consumer comparison requires a consistent total-cost perimeter. It includes fund operating expenses, transaction costs, contract administration, insurance protection, premium loads, surrender charges, financing or loan interest, and any advisory or intermediary compensation not already captured. Some expenses purchase a genuine service or guarantee; the evaluation should compare their incremental economic benefit to their incremental cost. The EU PRIIPs Key Information Document regime aims to make product features, risks and costs comparable before sale, but standardized disclosure cannot replace reading the underlying policy for the exact timing and contingencies of its charges.

Fund transfers, liquidity, and portfolio governance

A right to switch funds should be represented as an option constrained by eligible destinations, valuation rules, processing dates, possible switching charges, and minimum allocations. Where a contract requires a policyholder to designate investments, the resulting risk exposure changes through active elections and defaults alike. A default fund may reduce the effort of choosing, but it remains an investment position whose costs and risk properties should be identifiable. If linked assets are illiquid, valuation and settlement provisions create additional operational sensitivity; a contract may retain the power to replace options or impose extraordinary restrictions as permitted by its terms and law.

Currency denomination is another source of risk asymmetry. If the linked account is valued in one currency but the guaranteed death benefit or premium obligation is denominated in another, the insurer must analyze translation rules, embedded currency floors, and any mismatch between linked assets and guaranteed cash flows. A regulator assessing unit-linked investments under the Solvency II prudent-person guidance emphasizes investment selection in policyholders' interests and close asset coverage of unit-linked technical provisions. This is a supervisory interpretation of the European framework, not a promise of unconditional investment-value protection.

Policy loans, partial surrender, and the erosion of cover

Loans and withdrawals alter at least three ledgers: gross linked account value, outstanding indebtedness or encumbered value, and the benefit due at death. If death proceeds are reduced by an outstanding loan and accrued interest, an apparent guaranteed gross benefit may yield substantially smaller net proceeds. Loan rules may create a separate credited account, an interest spread, a collateral restriction, or a risk of lapse. Partial surrender can reduce either the fund account, the insurance sum, or both, according to the policy. A policyholder may therefore make an apparently modest liquidity withdrawal that has an amplified effect when it increases the net amount at risk and future cost-of-insurance charges.

The SEC variable-life guidance on policy loans explains the relationship between loans, lower cash value, possible death-benefit reductions, and lapse exposure. The literature on insurance behavior reinforces the need to model liquidity rights as exercised options rather than fixed contractual footnotes. A model that assumes all policyholders hold to the stated term may seriously misstate both consumer outcomes and the insurer's guarantee cost. For that reason, this dossier treats withdrawals and termination as endogenous scenario variables in later analysis.

Death-Benefit Protection and Contingent Guarantees

Defining the insured promise

The benefit payable upon death is a function of the policy's chosen option, account value, insurance face amount, insured age, premium history, contractual adjustments, and the time at which death occurs. In an elementary level-benefit arrangement, a benefit floor F might apply so that B_t = max(F,A_t), subject to any further minimum-benefit formula. The net amount at risk to the insurer is then N_t = max(0,B_t-A_t). When this simplified formula is operative, N_t increases as the market-linked account falls below F. The insurance undertaking must fund the difference between the cash value made available by linked investments and the guaranteed amount payable. If the contract instead pays only the prevailing unit account on death, its pure mortality protection can be small, absent, or supplied through another contractual term. A policy described commercially as unit-linked therefore requires a precise benefit reconstruction before its mortality-risk content can be inferred.

Another common design makes the death benefit equal to an account value plus a stipulated insurance amount, with contract-specific minimums, corridors or age adjustments. This produces a different exposure from a fixed floor: the insurance amount may stay relatively steady while the investment-related component rises and falls. A minimum death benefit stated as a multiple of premium paid can behave differently again. Premium-based floors may persist after market losses or be reduced by withdrawals; ratchet mechanisms may increase the floor at specified anniversaries; and return-of-premium terms can be conditional on contributions, persistency, and the absence of certain withdrawals. Each feature changes the contingencies under which a guarantee becomes valuable.

The SEC's explanation of variable-life death benefits distinguishes guaranteed minimum death benefits, policy features and the possibility that an insurer's contractual obligations can be altered by policy lapse. In actual underwriting and valuation, the benefit must be expressed as a schedule for every possible date of death, not as an advertised single number. A net payout can also reflect unpaid loans, premium debts, taxes or legally applicable offsets. The difference between a quoted face amount and the enforceable net death claim is therefore a first-order object of study.

Death-contingent exposure under market stress

Return to the hypothetical account developed above. Suppose the contract guarantees a $150,000 death benefit throughout the year and the policy remains in force. Following the +8% gross market scenario, the account is $105,780 and the insurer's additional death-contingent shortfall is $150,000 − $105,780 = $44,220. Under a −25% market scenario, the account is $73,275 and the shortfall rises to $76,725. Although the latter scenario leaves the policyholder with less accessible cash value, it creates $32,505 more pure insurance exposure to the insurer. The figures are conditional on exactly the stated level-benefit contract and do not imply that every product guarantees $150,000 or that the insurer loses the full benefit on a claim. Investment assets within the account ordinarily finance part of the payment.

For a single year with an assumed mortality probability q = 0.0015 and with death treated as occurring at the stated year-end valuation date, the undiscounted conditional expectation of the net insurer top-up is qN. This yields $66.33 in the rising-market example and $115.0875 in the falling-market example. Rounded to cents, the latter is $115.09. Both are exposure illustrations only: a legally determined premium would also depend on the full age and risk distribution, timing of death, mortality selection, expenses, profit and capital costs, policyholder behavior, reinsurance, hedging, and contractual charges. An account balance that changes during the year and a death date inside the year require a time-dependent benefit and mortality calculation, not this two-point approximation.

This example makes one central economic linkage visible: a minimum death-benefit guarantee embeds an equity-sensitive contingent payment in a mortality-contingent contract. Investment risk is allocated partly to the policyholder through account-value fluctuations and partly back to the insurer through the guarantee shortfall. The correlation between mortality and market conditions, if present, alters joint-tail costs; simply multiplying marginal average market and mortality outcomes can misrepresent the exposure. Mortality probability itself must be derived from a population relevant to the insured lives. A general-population death rate is not automatically interchangeable with an underwritten portfolio rate.

Guarantee valuation and market completeness

Brennan and Schwartz's pricing analysis of equity-linked insurance is an early financial-economics treatment of guaranteed benefits associated with investment-sensitive insurance. Its option-pricing logic clarifies why a return guarantee acquires value when downside market outcomes are contractually absorbed by an issuer. Extending such reasoning to life insurance requires mortality-contingent cash flows and a policy termination process. Market-traded components may be hedged with financial instruments in some circumstances, whereas mortality risk, behavior and discrete contractual terms may remain unhedgeable or only partially hedged. Regulatory capital and technical reserves must reflect the actual rulebook rather than an assumption that a perfect financial replication exists.

Møller's risk-minimization study of unit-linked contracts develops a mathematical perspective on investment-linked insurance with guarantees under incomplete markets. It provides a useful analytical reference for distinguishing hedgeable financial components from residual insurance risk; the applicability of any particular formula still depends on its model assumptions. Dynamic hedging itself has transaction costs, basis risk, model uncertainty and liquidity requirements. At the moment a market falls sharply, a contractual floor may become more deeply in the money while the insurer's available risk-hedging liquidity becomes more constrained. The economic value of a guarantee must consequently be distinguished from the operational capacity to fulfill it through adverse states.

A generic economic valuation expression emphasizes this structure. Let τ denote the random future death time, T the maximum duration, S_t the fund state, H_t relevant contractual history and D(t) a discount factor. The present value of a death top-up under an explicitly selected valuation measure can be expressed as E[D(τ) max(0,B_τ(S_τ,H_τ)−A_τ) 1_{τ≤T and in force at τ}], plus any separately valued contractual survival or surrender obligations. The indicator for an in-force policy is essential: a guarantee exercisable on death while coverage is active cannot be valued as if it survived every lapse. The expectation operator alone does not establish a valuation framework; financial market assumptions, mortality calibration, behavior and the required accounting or solvency basis must be specified.

Mortality deductions and feedback effects

Many flexible-premium policies assess a periodic cost-of-insurance charge that is related to the amount of insurance at risk, the insured's characteristics and contractual charge schedules. Under a simplified convention C_t^{COI} = c_t N_t, a decline in linked-account value increases the net amount at risk and may increase the deduction in dollars even when the charge rate c_t is unchanged. If the deduction is removed from the same linked account, the account falls further than it would from investment returns alone. This feedback can increase lapse vulnerability in a prolonged downturn, particularly where the policyholder cannot or does not supply additional premiums.

This arithmetic should be interpreted with care. Some contracts use a different cost-of-insurance base or rate, impose limits, use monthly processing or apply premium-based or specified guarantees that interrupt the simple loop. In other products, net amount at risk is defined in legally particular ways that differ from B−A because of statutory tax corridors, benefit options, or contract-defined cash values. The full recurrence must be reconstructed from the filed policy form and contract schedule. The generic loop nevertheless identifies what to test: declining investment values can increase coverage exposure precisely while reducing the means by which charges are paid.

The insurer's payment obligations and risk transfers

Investment-linkage does not dissolve the insurer's claims-paying obligation. At a covered death, the insurer must apply the valid contract provisions, identify the insured event and beneficiary, value the account according to the correct date and method, and calculate any guaranteed increment and contractual deductions. If investment assets are legally segregated for a defined purpose, that arrangement is relevant to policyholder protection and insolvency, but the legal priority of owners and beneficiaries depends on the governing national system and the specific structure. 'Separate account' in the U.S. and 'unit-linked fund' in another jurisdiction should not be treated as legally synonymous by default.

Reinsurance may transfer some mortality, catastrophe, excess death-benefit or guarantee exposure to a counterparty, while leaving the direct policy obligation with the original insurer unless applicable law and contractual arrangements provide otherwise. Hedge programs may target market factors while reinsurance addresses biometric or combined risks. A complete risk inventory therefore identifies the contractual risk borne by the policyholder, the direct insurer, separate-account assets, guarantor or derivative counterparties, and any reinsurer. It must also recognize that counterparty default, collateral, and mismatch can create secondary exposures. The product's advertised division between 'investment risk' and 'insurance risk' is only a starting point for this tracing exercise.

Persistency as a condition of protection

Guarantee availability usually depends on premiums and other conditions sufficient to keep the contract effective. Two customers with identical fund allocations and death-benefit formulas may experience different protection because one maintains contributions while the other misses required funding or makes a withdrawal that triggers a lapse. The insurer's investment in acquisition and underwriting at policy inception is similarly contingent on future premium and policyholder behavior. Death protection, account growth, future deductions and lapse must therefore be modeled as one contract path, with conditional branches, rather than as independent static tables.

The correct legal question at each date is whether the death coverage is in force and which continuation rights exist, including any grace period, no-lapse guarantee, reinstatement right, or premium reminder required by applicable law. Such provisions can preserve insurance even when one account metric suggests exhaustion, or terminate coverage despite an attractive historical illustration. Contract-specific documentation is decisive. The analytical distinction is between economic account sufficiency and legal policy effectiveness; each affects the other through the operative policy terms.

Contract-Risk Classification, Reporting, and Supervision

Classifying market risk, mortality risk, and conduct risk

Risk classification begins with the economic source of a loss, the person who absorbs it and the contract provision that determines its consequences. Market risk arises when linked assets change in value; mortality risk arises when insured deaths differ from the assumptions underlying contingent liabilities; longevity risk may be relevant to survival-linked features; liquidity risk affects asset transactions and policyholder withdrawals; persistency risk concerns the timing and selection of lapse, surrender and premium changes. Operational, legal, cyber, investment-management and distribution risks affect whether the intended financial design is actually delivered. These categories overlap in causal pathways but refer to distinct sources of uncertainty.

The policyholder typically bears material market risk in a variable investment account, yet the insurer may retain an investment-sensitive obligation through guaranteed benefit floors, fixed crediting, surrender provisions, or mismatched assets. Policyholder choice over underlying funds may change the distribution of the guarantee's future value. The insurer may consequently have reason to impose eligible-fund menus, switching restrictions or guarantee-specific risk charges. These features are economically consequential; they must be described accurately in product information and assessed for consistency with contract promises and consumer interests.

It is useful to classify a contract at four different documentary levels: legal coverage, economic cash-flow behavior, accounting recognition, and supervisory treatment. A product can be an insurance contract under national law, an investment product for certain distribution protections, a contract containing substantial financial guarantees, and an IFRS 17 insurance contract or investment contract with discretionary participation according to the precise applicable facts. A single label cannot substitute for those independent tests. This is an interpretive method derived from the documents under study, not a newly instituted classification doctrine.

United States: separate accounts and the joint regulatory perimeter

In the U.S., variable life illustrates how insurance law and securities regulation can intersect without collapsing into a single system. The SEC's Form N-6 registration rule establishes a securities disclosure architecture for separate accounts registered as unit investment trusts offering variable life insurance. The NAIC model-law catalogue lists a Variable Contract Law and Variable Life Insurance Model Regulation. NAIC models can inform state adoption and harmonization, but are not themselves binding enactments in every state. A jurisdictional analysis must identify the enacted state law and relevant regulator instruments, rather than infer legal uniformity from a model's existence.

A prospectus reveals investment objectives, account options, fees, surrender schedules, restrictions and significant risks, whereas the legally enforceable policy and endorsements determine actual insurance promises. The public SEC filing system contains historical variable-life prospectus filings that illustrate how charges and account terms were disclosed. A historic filing is evidence of a particular filing and date; it cannot be presented as a currently offered product or as a universal form. The research task is to pair the versioned prospectus with the corresponding policy form, issue jurisdiction, benefit option and rider elections. A reader who holds only a marketing summary may otherwise miss contract terms materially changing the outcome.

The official SEC consumer explanation of variable life underscores the need to consider fees and risks, adequacy of premiums and the investor's long investment horizon. Contract suitability and securities distribution duties depend on the applicable law and professional role. This research therefore does not translate U.S. compliance descriptions into advice or assume that the SEC supervises every insurer obligation arising under state law. The institutional distinction matters both for the location of regulatory responsibility and for how a consumer identifies relevant disclosures or complaint channels.

European Union: distribution, key information, and product governance

The Insurance Distribution Directive creates a European framework for insurance distribution, including additional provisions for insurance-based investment products. Its distribution rules address customer needs, disclosures, conflicts of interest and, within applicable conditions, suitability and appropriateness. Investment-related suitability analysis is more demanding than verifying that the customer can pay the first premium: objectives, ability to bear financial loss, investment knowledge and the capacity to maintain insurance over time affect the real economic fit of the product. Member-state implementation and the precise transaction context determine enforceable duties.

The PRIIPs Regulation provides the statutory basis for a Key Information Document for products within its scope. Its framework addresses risks, costs, performance scenarios and the conditions of holding the product. The research value of this disclosure is its potential to provide a comparable account of contract economics. Yet the key-information format necessarily compresses product-specific policy features; detailed conditions on mortality deductions, death benefit formulas, withdrawals, loans, switching and lapse remain essential for a complete contract reconstruction. In analysis of consumer comprehension, the standardized presentation should be tested against the actual contractual consequences of adverse scenarios.

The EU regulatory treatment of unit-linked contracts also raises asset-side duties. The Solvency II investment guidance addresses the prudent-person framework applicable to assets used for unit-linked obligations. The essential analytical point is that alignment of assets with linked obligations is important, while separately promised guarantees, additional risks and supervisory capital requirements can remain on the insurer. A contract may pass investment returns to the policyholder while still creating material insurer solvency exposure. The precise Solvency II provisions, national implementation and relevant prudential rules must be checked for each entity and valuation date.

IFRS 17 and financial reporting

IFRS 17 is an accounting framework for insurance contracts applicable in jurisdictions adopting it; its mandatory effective date for applying entities is annual periods beginning on or after January 1, 2023. The IFRS Foundation's official IFRS 17 overview explains identification of significant insurance risk, measurement of fulfillment cash flows, the contractual service margin and separation of specified distinct components. A life-insurance product's commercial title does not independently establish how it will be accounted for. The actual terms must be assessed for whether significant insurance risk is transferred, the presence of distinct components, and any relevant direct participation features.

For eligible direct participating contracts, IFRS 17 contains a variable-fee approach under specified conditions. The insurer's share of the returns on identifiable underlying items may form part of its fee for service, but this does not imply that all unit-linked products automatically qualify for that approach. The contract must meet the operative criteria, including the relationship to clearly identified underlying items and the variability of cash flows. An insurer's financial statements may consequently reflect service results, changes in financial assumptions and the accounting treatment of guarantees differently from the policyholder's statement of fund value. Accounting recognition and cash-value disclosure answer different questions.

The IFRS Foundation's description of contract measurement supports a useful contrast: the insurer's liability measures obligations under a reporting basis, while a policyholder's disclosed account value follows policy valuation terms. Neither is interchangeable with the other or with an economic valuation of a hypothetical guarantee. A defensible empirical comparison of accounting outcomes specifies whether it uses the general measurement model, premium allocation approach where eligible, variable-fee approach where eligible, or a particular national accounting regime. This monograph does not reconstruct the full subscription text of IFRS 17 or assert the eligibility of an unspecified contract.

Conduct, conflicts, and product oversight

The distribution of policy charges and commission incentives can influence how a contract is sold. Where acquisition charges are front-loaded, surrender penalties protect recovery of acquisition expenses and may expose early terminators to disproportionate cost. Where distributors receive investment- or premium-dependent compensation, their incentives may diverge from a customer's need for insurance protection, liquid savings or low-cost investment exposure. Governance should assess conflicts within the actual law, product design, remuneration structure and customer segment instead of attributing misconduct merely from the presence of compensation.

EIOPA's revised value-for-money benchmark methodology, issued July 6, 2026, explicitly replaces its 2024 methodology. This date is important: applying the superseded version as if it were the current institutional methodology would distort a November 2026 analysis. Benchmarks offer a tool for comparing costs and relevant benefits among sufficiently comparable insurance-based investment products. They do not alone determine the fairness or suitability of a specific contract, particularly when death-cover content, guarantee cost, policyholder age and risk category materially differ across products.

The governance question extends beyond disclosure completeness to contract functionality. Stress testing should evaluate whether customers understand premium flexibility, the conditions under which cover persists, and the fact that cash value can fall below aggregate contributions. Surrender value, account value, death benefit and a quoted investment return are different quantities. Their distinction should survive translation into sales illustrations, key information, annual statements, policyholder portals and complaints processes. Product approval and distribution monitoring can then use both quantitative risk outcomes and observed consumer behavior rather than assuming that formal disclosure alone secures comprehension.

Empirical Evidence, Comparative Tests, and Adverse Scenarios

What available evidence can establish

Empirical research on investment-linked life policies faces a distinctive sampling problem: the economic unit is a contract whose outcomes depend jointly on product terms, risk characteristics, investment choices and persistence. A market average of investment performance cannot establish the quality of death protection, while average mortality experience cannot establish the value of fund choices. Research needs longitudinal observations of policy status, premium transactions, unit holdings, charges, guarantees, surrenders and claims, ideally matched to dated versions of the underlying contractual forms. National supervisory aggregates are useful for identifying common issues and market structure, but they do not automatically identify causal effects of one contract feature.

EIOPA's Costs and Past Performance Report 2026, published April 1, 2026, examines products available on December 31, 2024, using a performance reference period from January 1, 2020, through December 31, 2024. Its report page states that 175 undertakings participating in the exercise represented more than 60% of EEA unit-linked and profit-participation premiums; the sample includes 5,906 products selected to cover top-selling, expensive and inexpensive products and different holding periods, risk levels and underlying assets. These figures describe the specified survey and product sample. They are not a census of every contract sold in every European country, a mortality study, or evidence that each product had the same insurance coverage. The deliberate inclusion of price extremes and high-volume products must be reflected in any inference made from sample-wide averages.

The report's value for this dossier lies in its documented frame for comparing costs and observed past performance. A researcher can construct matched product groups by minimum holding period, investment exposure, policy structure and inclusion of a specified insurance benefit, then investigate whether cost differences persist. That comparison still faces selection and survivorship difficulties: only products within the report's stated eligibility window enter, the period includes distinct market environments, and changes in fund mix can alter measured returns. In the absence of contract-level pricing and coverage terms, a cost gap cannot be automatically labeled an excess charge. The guarantee could be different, the biometric cohort could be different, or an expense may be counted in a different component.

Lapse behavior, financial distress, and selection

Policy surrender is an economic decision with behavioral and contractual determinants. Eling and Kiesenbauer's analysis of life-insurance lapse determinants uses a large German life-insurance policy dataset to investigate determinants of lapse behavior. The authors' product and market setting, the distinction between policyholder and policy observations and the time of observation matter for transportability to unit-linked policies elsewhere. An observed association between a variable and lapse cannot be treated as a universal causal effect. Policy age, tax incentives, acquisition charges, liquidity needs and premium obligations may covary with behavior in ways that complicate comparison.

Gottlieb and Smetters' study of behavioral life-insurance lapses documents the importance of behavior in a life-insurance context. Their empirical findings and modeled mechanisms caution against assuming that every policyholder optimizes continuously in response to market conditions. Inattention, liquidity constraints and changing household circumstances may influence the retention of an insurance product whose long-term benefits depend on continuous coverage. Their studied population is not a representative global unit-linked portfolio, and the paper does not establish a universal lapse rate for the products considered here. It establishes a mechanism to test in a more specific contract population.

Lapse selectivity can also change the insurer's residual insurance risk. If people with relatively high mortality risk are more likely to retain coverage, the surviving portfolio may have different claim probabilities from an initially underwritten cohort. If those under financial stress exit despite a valuable guarantee, the insurer's guarantee liability can be affected by both the removal of exposure and the changing composition of remaining lives. These effects can point in different directions. A credible model therefore estimates lapse conditional on duration, age, contract value, guarantee moneyness, premium adequacy and relevant economic circumstances, while tracking mortality selection. A regression on calendar-year aggregate surrenders alone cannot identify the complete feedback.

Stress test: account depletion and death-benefit top-ups

The following two-state illustration uses a single policy solely to isolate mechanical effects. Both states begin with $100,000, no additional premium or withdrawal, a fee of 1.5% of value after return, and a $600 fixed/insurance deduction at year end. The guaranteed death benefit is $150,000 throughout the year if the contract remains effective. The assumed one-year mortality probability is 0.0015. There is no discounting, no mid-year death valuation and no insurer expenses beyond those already shown. Outcomes under the two stated gross market returns are:

Contract variable Rising-market state Falling-market state
Gross market return +8% −25%
Account before percentage fee $108,000 $75,000
Account after 1.5% fee, before fixed deduction $106,380 $73,875
Account after all stated deductions $105,780 $73,275
Guaranteed death benefit $150,000 $150,000
Insurer top-up conditional on death $44,220 $76,725
Expected top-up at q = 0.0015 $66.33 $115.09

The table shows a deterministic sensitivity, not the distribution of real investment returns, mortality or insurer profit. It omits policy dividends, transaction timing, tax, interest-rate term structure, minimum nonforfeiture provisions and asset-side hedging. If the policy provides a flexible premium and monthly deductions, this annual simplified representation may overstate or understate actual year-end account value. Its valid scientific use is diagnostic: it shows why a risk system should recompute both account value and net death exposure after a market shock rather than stress either one in isolation.

Now suppose a policy remains in force while its contractual premium funding is suspended. Under a generic positive recurring deduction D_t, the account declines according to fund returns net of charges and may eventually reach a contractual insufficiency or grace-period trigger. The date of exhaustion is path-dependent, so the annual average return is inadequate to identify it. Even a fund that earns a positive average over several years can experience early losses that drain an account while charges continue. This sequence risk becomes especially important when death-benefit costs rise with age or with a market-sensitive net amount at risk. No-lapse provisions or contractual premium guarantees can modify the outcome; the stress test must implement them explicitly.

Stress test: cumulative fees and holding duration

A second illustration isolates investment-wrapper drag, independently of mortality costs, with a constant gross annual return of 6% over 20 years on an initial $100,000. If the insurer and fund together apply a 1% annual proportional fee after each gross return, the terminal value is 100,000(1.06 × 0.99)^20. If the relevant annual fee is 2%, the value is 100,000(1.06 × 0.98)^20. The outcomes are $262,313.84 and $214,110.92, respectively, a $48,202.91 difference after rounding. The difference measures the cumulative account impact of exactly one percentage point under these assumptions; it is not a claim that a higher fee is unjustified where a richer mortality guarantee or other services are provided. Stating the investment and insurance components separately is essential for assessing the trade-off.

Under a variable return sequence, the timing of fees can change the difference further. Premium-based fees may be paid at inception, fund-level fees may already appear in the return history, mortality charges are often deducted periodically from a declining or increasing net amount at risk, and surrender penalties may apply only during specified years. An apparently simple comparison of total expense ratios across a conventional fund and a variable life policy may omit both insurance value and costs outside the fund. A valid matched comparison holds insurance protection constant, identifies all price components, adjusts for tax rules in the relevant jurisdiction, and evaluates comparable liquidity and termination conditions.

Comparative research design across contract families

A useful international comparison should specify, for each studied policy, its issuing insurer and regulatory domicile, insured-person eligibility, coverage term, insured death trigger, premium obligation, account-unit valuation, investment selection rights, benefit floor, loan and withdrawal provisions, surrender charges, embedded options and disclosure documents. It should record the exact contract-form edition and any endorsements because products with the same name can change over time. For U.S. variable life, prospectus records and state-filed forms may be needed together; for European unit-linked policies, contractual conditions, key information, national distribution rules and solvency disclosures may be relevant. Comparing a single U.S. flexible-premium policy to an EU fixed-premium savings insurance wrapper without adjustment would confound jurisdictional and product differences.

A defensible observational study can stratify by benefit formula and premium pattern before estimating the relationship between fees and persistence. It should also adjust for insured age, underwriting class, issue year, sales channel, investment option, fund volatility and macroeconomic conditions. A quasi-experiment could exploit a documented change in a permissible contractual charge or guarantee for otherwise comparable policy cohorts, but causal interpretation would require evidence that the change was not accompanied by shifts in underwriting, distribution or customer composition. Where such identifying variation is absent, the analysis should remain a transparent observational comparison. No new empirical dataset is claimed in this monograph.

Counterevidence and sensitivity analysis

Claims that investment-linked policies systematically underperform alternative savings vehicles require a matched-benefit benchmark. A term-life-plus-separate-investment comparison can be informative, yet the result depends on underwriting cost, availability of tax treatments, premiums, persistence, liquidity and transaction constraints. An alternative with a lower account fee may provide no comparable death-benefit floor, while a high-charge policy may still be a poor match for a purchaser who needs little protection and values liquidity. The research task is to distinguish those propositions, not to produce a market-wide ranking from incomplete product facts.

Sensitivity analysis must include the direction of adverse dependence. Equity crashes and surrender rates may be correlated, but correlation can be positive for liquidity-driven exits and negative where a valuable guarantee discourages surrender. Mortality experience may be relatively stable under ordinary conditions while extreme events create stress. Changes in interest rates affect discounting and portfolio asset returns differently. Across different markets, tax and consumer-protection rules also create incentives that are not embedded in a gross return path. A robust result is one that survives clearly stated plausible alternatives, or else identifies the exact assumption upon which it depends.

Evidence limitations and reproducibility

The evidentiary base combines published official summaries, source legal instruments, regulator pages, archival policy materials and bibliographic or abstract-level access to academic papers. It does not provide a complete contractual survey, underlying EIOPA firm-level product observations, all national implementing statutes, original household survey records or a subscriber's full text of every academic work. Legal provisions are discussed at the level for which publicly accessible information has been checked. The numerical illustrations are reproducible independently but have no statistical confidence interval because their inputs are author-selected scenarios. The appropriate reproducibility record consists of exact links, dated access, stated equations, parameter values and a clear distinction between a calculated result and a reported measurement.

The main evidentiary asymmetry is instructive. Supervisory texts define duties and classifications more precisely than they describe the actual distribution of future returns; empirical surveys show patterns across selected products more effectively than they disclose each contract's enforceable claim formula. A sound contract study must connect, but never equate, those kinds of evidence. The most material unresolved scientific needs are policy-level longitudinal microdata with reliable contract-version identifiers, publicly replicable decomposition of total expenses, and tests of how lapse interacts with guarantee moneyness and mortality selection. Those needs define a future research agenda rather than an excuse to infer unobserved facts today.

Scientific Synthesis and Future Research

A contract as a contingent allocation of several risks

The preceding chapters establish that a variable or unit-linked life contract is a linked system of promises, investment positions and time-dependent behavioral choices. The investment account expresses how a contract allocates some asset-performance exposure; the death-benefit schedule specifies the insurer's contingent promise; deductions finance insurance, administration and other services; surrender rules and premium flexibility determine whether future promises remain available. These elements operate together. A change in account value can alter both the policyholder's surrender proceeds and the insurer's amount at risk; a withdrawal can alter future deduction rates, guarantee levels and the probability of lapse; a policyholder's decision to retain coverage changes the population over which mortality costs emerge.

The clearest analytical unit is the contract path under specified circumstances. Its necessary data are the policy form, dated endorsements, account history, guarantee schedule, charge basis and insured-event conditions. A single current account balance is an incomplete state description when the death guarantee depends on earlier account highs, cumulative premiums or withdrawals. Where a ratchet, vesting rule or persistency condition is present, the contract has memory: the benefit due at a future date depends on documented past events, not solely on contemporary prices. The same reasoning applies to loans, account switches and no-lapse provisions. This is a synthesis of the contract mechanics, not an assertion of a proprietary new model.

Implications for pricing and capital adequacy

A prospective actuarial analysis must simulate or otherwise evaluate coupled trajectories of linked assets, biometric claims, charge emergence, premium funding, surrender and optional elections. For each scenario it must apply exact policy terms before identifying the insurer's residual liability. Under a fixed benefit floor, worsening market performance tends mechanically to increase the conditional top-up per death, subject to the policy remaining active. Under an account-plus-insurance design, the corresponding risk pattern can differ. The correct price, reserve, reinsurance strategy and hedging program must be matched to the actual benefit structure and valuation basis.

Asset matching for linked obligations can reduce some investment-market mismatch, but it cannot remove a guarantee's incremental insurer exposure by nomenclature alone. Similarly, a sophisticated derivative hedge may reduce financial sensitivities while leaving behavioral and biometric uncertainty. The responsible valuation record states which sources of risk are priced using market-consistent techniques, which are estimated actuarially, and which remain subject to explicit uncertainty or capital treatment. This separation also protects against the false appearance of precision when unknown correlations are compressed into a single deterministic expense allowance.

Implications for consumer outcomes

Consumer value rests on the services and contingencies a policy actually supplies relative to its full costs. An investment-linked contract can provide a combined household protection and long-term investment function, but its cash value is generally sensitive to market outcomes and costs. A guaranteed death benefit is not equivalent to a guaranteed surrender value; a flexible premium is not equivalent to a permanent waiver of future funding; a fund choice is not a guarantee of liquidity at the moment of surrender. Good product disclosure makes these differences legible at inception and through annual communication. A customer who cannot tell whether the coverage survives a prolonged downturn cannot reliably evaluate its most consequential promise.

The EIOPA 2026 product-cost survey and the revised benchmark methodology illustrate the growing supervisory interest in comparative cost and value. The causal research frontier lies beyond a product's listed fee: it concerns how charging structures, guaranteed benefits, sales incentives and customer persistence jointly affect realized protection and savings. This study's contract-centered reading of the evidence provides a way to formulate that question without converting a regulator's benchmark into a legal verdict or a consumer recommendation.

International comparability and institutional interpretation

The same economic exposure may reside in different legal structures. U.S. separate-account regulation emphasizes the intersection of securities registration and insurer-issued contracts; EU retail investment protections focus on regulated distribution and key information for applicable products; IFRS 17 addresses financial reporting for qualifying contracts in entities applying that framework. Solvency and prudential arrangements ask whether the insurer has sufficient assets and risk controls to fulfill obligations under stress. These are institutionally distinct questions. International comparison requires an explicit correspondence table between legal concepts rather than an assumption that 'variable', 'unit-linked' and 'insurance-based investment product' are perfectly interchangeable.

A minimum scientifically adequate comparative file should preserve source-country terminology alongside an operational translation of the benefit formula. It should mark whether surrender value is guaranteed, whether death protection is fixed or variable, which party selects investments, which charges vary with net amount at risk, and which rules make the contract effective or extinguish it. It should also document the first available and current versions of significant source texts. Without this provenance, shifts in regulation or contract design can easily be mistaken for differences between countries.

Research agenda

Future research should first produce contract-level linked datasets that connect product editions to actual account, premium, guarantee, surrender and death-claim histories. Second, it should evaluate the value of embedded guarantees using transparent assumptions for market dynamics, mortality selection and policyholder behavior, with separate sensitivity to each source. Third, it should construct matched comparisons of insurance-plus-investment contracts and feasible unbundled alternatives, preserving comparable cover and liquidity. Fourth, it should test consumer comprehension of dynamic lapse mechanisms rather than ask only whether a static cost table was read. Fifth, international studies should preserve jurisdiction-specific legal predicates and differentiate mandatory rules from supervisory guidance and model legislation. Each of these undertakings would require additional original observations or deeper contract archives beyond the present documentary evidence.

Conclusions

Variable and unit-linked life insurance distributes the consequences of financial investment and life-contingent events through a single evolving contract. The account receives specified investment returns, while the insurer undertakes the benefits actually promised by the policy. The economic boundary between these obligations is set by benefit floors, premium and charge terms, withdrawals, contract persistence and the legal treatment of linked assets. Those provisions, rather than the commercial product label, determine the actual distribution of risk.

The transparent calculations show the interaction precisely. In the stated illustrative level-benefit policy, a gross one-year return of +8% leaves an account of $105,780 and a guaranteed death-benefit top-up of $44,220; a −25% return leaves $73,275 and raises the top-up to $76,725. The increased insurance exposure occurs in the same state where accessible savings decline. For flexible-premium products, recurring deductions can also reduce the account's ability to sustain coverage, particularly when mortality charges depend on the net amount at risk. Modeling the investment account without the death benefit, or the death benefit without account depletion and lapse, omits essential contract mechanics.

The comparative record establishes distinct legal and institutional perspectives. U.S. variable-life arrangements may combine separate-account securities disclosure with state insurance regulation. EU insurance-based investment rules add product-information and distribution duties according to their legal scope. IFRS 17 supplies an entity-level reporting framework with its own significant-insurance-risk tests and, where appropriate, direct-participation criteria. None of these classifications can be inferred solely from the phrase 'unit-linked'. Actual product conditions and the operative jurisdiction remain decisive.

The empirical evidence has legitimate but bounded significance. EIOPA's 2026 costs and past-performance exercise provides a defined large product sample, while academic studies of lapse behavior identify decision mechanisms and selection issues relevant to contract economics. The data do not by themselves determine the value of a specific guarantee or establish a universal quality ranking. More complete conclusions depend on linked contract-level information and genuinely matched comparisons, including the insurance benefit, total charges, liquidity, taxes where applicable and customer capacity to maintain coverage.

The resulting research finding is methodological and substantive. Variable and unit-linked life insurance must be studied simultaneously as a contingent-claims contract, an investment account, a sequence of policyholder options, a source of insurer risk and a legally supervised retail product. Reconstructing those elements from dated primary documents, testing their interaction through reproducible scenarios, and preserving the difference between reported evidence and original inference provides the basis for sound scientific evaluation. This monograph offers that integrated analysis without claiming a new proprietary theory or an original empirical dataset.

References

  • Brennan, Michael J., and Eduardo S. Schwartz. (1976). “The Pricing of Equity-Linked Life Insurance Policies with an Asset Value Guarantee.” Journal of Financial Economics 3(3): 195–213. DOI: 10.1016/0304-405X(76)90003-9.

  • Eling, Martin, and Dieter Kiesenbauer. (2014). “What Policy Features Determine Life Insurance Lapse? An Analysis of the German Market.” Journal of Risk and Insurance 81(2): 241–269. DOI: 10.1111/j.1539-6975.2012.01504.x.

  • European Insurance and Occupational Pensions Authority (EIOPA). (2026a, April 1). Costs and Past Performance Report 2026. Official report and methodology.

  • European Insurance and Occupational Pensions Authority (EIOPA). (2026b, July 6). Revised Methodology on Value for Money Benchmarks. Official revised methodology.

  • European Insurance and Occupational Pensions Authority (EIOPA). (Accessed 2026). Questions and Answers on Regulation, Question 2249, concerning Solvency II investment duties for unit-linked assets. Official supervisory Q&A.

  • European Parliament and Council of the European Union. (2014, as amended). Regulation (EU) No 1286/2014 on Key Information Documents for Packaged Retail and Insurance-Based Investment Products (PRIIPs). Official EU legislation.

  • European Parliament and Council of the European Union. (2016, as amended). Directive (EU) 2016/97 on Insurance Distribution (recast). Official EU consolidated text.

  • Gottlieb, Daniel, and Kent Smetters. (2021). “Lapse-Based Insurance.” American Economic Review 111(8): 2377–2416. DOI: 10.1257/aer.20160868.

  • IFRS Foundation. (2023 effective; accessed 2026). IFRS 17 Insurance Contracts. Issued-standard overview, significant insurance risk, fulfillment cash flows and service-margin descriptions. Official standard overview.

  • Møller, Thomas. (1998). “Risk-Minimizing Hedging Strategies for Unit-Linked Life Insurance Contracts.” ASTIN Bulletin 28(1): 17–47. DOI: 10.2143/AST.28.1.519077.

  • National Association of Insurance Commissioners (NAIC). (Accessed 2026). Model Laws, including Variable Contract Law, Model No. 260, and Variable Life Insurance Model Regulation, Model No. 270. Official model-law catalogue.

  • Securities and Exchange Commission (SEC). (2002, April). Registration Form for Insurance Company Separate Accounts Registered as Unit Investment Trusts That Offer Variable Life Insurance Policies, Form N-6 adoption. SEC adopting release.

  • Securities and Exchange Commission (SEC). (2001). Filed variable-life insurance registration materials, Form S-6/A, archival EDGAR text, accession 0000928389-01-500264. SEC EDGAR archival filing.

  • Securities and Exchange Commission (SEC). (2001). Filed variable-life insurance registration materials, Form S-6, archival EDGAR text, accession 0000928389-01-500216. Additional SEC EDGAR filing.

  • Securities and Exchange Commission, Office of Investor Education and Advocacy. (Accessed 2026). Variable Life Insurance. Investor.gov educational material. SEC investor explanation.